This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Pipeline OverviewITM-11 for Neuroendocrine Tumors (GEP-NETs)ITM-31 for GlioblastomaITM-24D / ITM-22 for Prostate CancerITM-55D & ITM-52 for Ovarian Cancer / NSCL AdenocarcinomaITM-41 for Osteosarcoma / Bone MetastasesPartnering OpportunitiesExpanded Access Program / Managed Access Program Overview

Partnering Opportunities

ITM as a Partner

Apart from bringing our own innovative Precision Oncology candidates to the market, we are always happy to discuss potential partnering opportunities.

We are always seeking innovative drug discovery partnerships, ideally fusing your target know-how with our leading radioisotope platform technologies to develop next generation diagnostic and therapeutic agents that will help fight serious and difficult to treat cancer diseases.




Partnering Contact

Dr. Konstantin Zhernosekov